Connor, Clark & Lunn Investment Management (CC&L)
XENE icon

Connor, Clark & Lunn Investment Management (CC&L)’s Xenon Pharmaceuticals XENE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio XENE Stock Details XENE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,799
Closed -$229K – 1481
2022
Q4 		$229K Buy
+5,799
New +$229K ﹤0.01% 1032
2022
Q2 		– Sell
-7,658
Closed -$234K – 1218
2022
Q1 		$234K Buy
+7,658
New +$234K ﹤0.01% 921